Source: Axios
“Food and Drug Administration Commissioner Marty Makary is stepping down after a turbulent 13-month term marked by organizational upheaval, controversies over drug approvals and tensions with the White House. Kyle Diamantas, the agency’s deputy commissioner for food, will serve as acting commissioner, according to sources familiar. … Makary, a Johns Hopkins physician and researcher, faced a series of controversies over abortion pills, flavored vapes, vaccines and rare disease drugs as the agency he oversaw underwent substantial turnover. He faced internal criticism for not accommodating some of President Trump’s priorities, along with complaints from health care investors about unpredictable regulatory decisions that rejected some promising drugs.” (05/11/26)
https://www.axios.com/2026/05/12/makary-out-fda-chief-turmoil